{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} IBD LIVE Case Series--Case 6: Persistent Skin Lesions in a Patient with Crohn's Disease: You Hear Hoof Beats and Discover a Zebra

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

IBD is also pleased to inform our readers that this CME activity is now eligible for the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) credit based on the most recent collaboration between the ABIM and the ACCME. In order to receive ABIM MOC for this CME activity each participant will need to make sure that the information on their profile for the CME platform (where his activity is located) is updated with 1) Their DOB-Month and Day only and 2) That they have selected that they are board certified in the profile via the ABIM. When this selection is made they will be required to enter their ABIM number. (Which is assigned via the ABIM). Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. The Lippincott Continuing Medical Education Institute will submit participant completion information to ACCME for the purpose of granting ABIM MOC Points.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain the side effects of medications used to treat IBD, particularly anti-TNFs.
  2. Recognize the various types of skin lesions that may occur in patients with IBD, focusing on those that arise among patients on immunosuppressants.
  3. Be cognizant of the presentation and treatment of PG in patients with IBD.
  4. Describe the various types of mycobacterial infections that may occur among patients with IBD, especially those that are on anti-TNFs.
  5. Describe the risk factors for developing a Mycobacterial marinum infection and how it may present dermatologically.
  6. Explain how to diagnose and treat a Mycobacterial marinum infection.

Disclosures

J. B. Greer holds a grant from Abbvie and is a shareholder of Alexion Pharmaceuticals.; M. D. Regueiro serves on the Advisory Boards and consults for Abbvie, Janssen, Pfizer, Takeda, and UCB.; D. G. Binion has grant support from Janssen, Merck, and UCB and has received honoraria from Janssen, UCB and Synthetic Biologics.; H. H. Herfarth receives consulting fees from Pfizer, Celltrion, Samsung, Merck, and UCB.; C. A. Siegel serves as a consultant to Abbvie, Amgen, Lilly, Janssen, Sandoz, Pfizer, Prometheus, Takeda, UCB, has delivered CME activities to American Regent, Abbvie, Janssen, Pfizer, Takeda, and has received grant support from Abbvie, Janssen, Pfizer, Takeda.; F. A. Farraye serves on the Advisory Boards of Abbvie, Janssen, Merck, Pfizer, and Takeda; consults for Braintree; has grant support from Merck, Prometheus, and Takeda, and is a shareholder of Cellceutix.; I. E. Koutroubakis consults and serves on the Advisory Boards of Abbvie and MSD.; M. H. Brand serves on the Speakers Bureaus of Abbvie, Gilead, and Takeda.; R.K. Cross holds grants from Abbvie and serves on Advisory Boards and consults for Abbvie, Janssen, Takeda, and UCB. and their spouses/life partners (if any) have no financial relationships with or financial interests in, any commercial companies pertaining to this educational activity. All authors, faculty and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations pertaining to this educational activity.

Price: FREE

Credits:

  • ACCME 2.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Planner
Professions: Physician
Test Code: IBD1116
Published: November 2016
Expires: 1/1/2026
Sources: Inflammatory Bowel Diseases
Required Passing Score: 6/8 (75%)
Authors: Dhyan Rajan, MD, Julia B. Greer, MD, MPH, Miguel D. Regueiro, MD, Leonard Baidoo, MD, David G. Binion, MD, Hans H. Herfarth, MD, PhD, Corey A. Siegel, MD, Douglas J. Hartman, MD, Francis A. Farraye, MD, MSc, Ioannis E. Koutroubakis, MD, PhD, Myron H. Brand, MD, Emmanuelle D. Williams, MD, Alka Goyal, MD, and Raymond K. Cross, MD, MS
Categories: Gastrointestinal
Specialties: Gastroenterology
Topics: Crohn's Disease , Skin Lesions